The development of novel reagents and antibiotics for combating multi-drug resistance bacteria has received significant attention in recent years. In this study, new
INTRODUCTION
The rise of multi-drug-resistance in bacteria is now considered a critical healthcare issue worldwide and the development of alternative antimicrobial agents that kill bacteria by new mechanisms is of paramount importance for overcoming this global healthcare challenge.
Hospital-acquired infections such as those caused by Gram-positive pathogens, including the methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE), have resulted in an estimated 23,000 deaths annually in the United States alone. 1 In Europe, MRSA infections affect more than 150,000 patients annually, incurring extra inhospitable costs worth 380 million EUR per year. 2 Several strategies have been exploited in recent years to identify more effective alternative antimicrobial agents, including the development of the iChip 3 (isolation chip) which allows the screening of soil microorganisms that were previously 'unculturable' in the laboratory. The use of this technology led to the discovery of teixobactin, 4 a highly potent antibiotic in fighting Gram-positive pathogens such as MRSA by inhibiting the bacteria cell wall synthesis. In addition, antimicrobial peptides (AMPs), which exert their bactericidal properties by physically damaging the bacterial cytoplasmic membrane instead of targeting intracellular targets, has been shown to be effective against a wide spectrum of bacteria. 5, 6 However, the synthesis of AMPs usually involve laborious multi-step procedures. In addition, AMPS are generally known to be haemolytic, thus limiting their
application.
An alternative approach in the development of new antimicrobial agents lies in the use of synthetic polymer chemistry. Over the last few decades, advances in controlled polymerization has led to a paradigm shift in the widespread application of well-defined synthetic biomaterials using functional macromolecules and nanoparticles produced by techniques such as (Ncarboxyanhydride (NCA)) ring-opening polymerization (ROP) 7, 8 and reversible additionfragmentation chain transfer (RAFT) polymerization 9 which have found their way into various applications, including drug or gene delivery systems, [10] [11] [12] [13] tissue engineering 14, 15 and biosensing. 16, 17 The ability to efficiently tune the chemical and physical characteristics (such as the functionality, size and shape), and ultimately the biological properties, of the bionanomaterial by simply controlling the polymerization feed compositions and reaction conditions makes polymeric systems highly attractive and applicable in the biomedical field. There are various types of antimicrobial polymer systems that have been previously developed, [18] [19] [20] [21] [22] mostly mimicking the amphiphilic feature of AMPs. While these nanomaterials have excellent antimicrobial activity, most are inherently cytotoxic towards human cells, as was observed for, which limits their potential clinical application. Thus, it is essential that the antimicrobial agent is not only effective in combating pathogens but must also demonstrate minimal toxicity towards human cells.
Herein, the development of a new antimicrobial agent with good biocompatibility in the form of glucosamine-functionalized star polymers is described. This star polymer, which is comprised of polylysine and polyglucosamine-based arms radiating from a central cross-linked core, was generated using a combination of various modern synthetic polymer chemistry protocols including RAFT polymerization, 9 NCA-ROP 7 and click chemistry. [23] [24] [25] The compounds produced exhibited selective killing of Gram-positive over Gram-negative pathogens, were nonhaemolytic and exhibited low cytotoxicity towards mammalian cells. The rationale behind the design of this nanoparticle is based on the ability of polylysine to induce bacteria death, whereas the glycopolymer may provide biocompatibility to human cells and the capability to infiltrate the peptidoglycan layer found only in bacteria (because of its resemblance to the peptidoglycan structure). By adjusting the chemical composition, specifically the ratio of polylysine to polyglucosamine-based arms, the antimicrobial activity and mammalian cell biocompatibility can be modulated. It is hypothesized that the star architecture offers a distinct advantage over linear analogues in terms of having better mammalian cell biocompatibility as the polyglucosamine-based arms can effectively shield and reduce the propensity of the cationic polylysine arms from interacting with other cells, thereby decrease cytotoxicity when the arms are 'locked' in a nanoparticle form. The results from the compounds developed here suggest that these compounds represent a structure that can be further modified and optimised for the subsequent development of antimicrobial agents for clinical applications.
EXPERIMENTAL SECTION
Materials. The concentrated solution was re-precipitated twice into DEE (100 mL) and dried in vacuo to yield the RAFT-functionalized poly(Z-L-lysine) as a yellow solid (620 mg, 69 wt%); GPC-DRI (DMF): M n = 4100 g mol -1 , Ɖ = 1.6. General linear polymer formation via RAFT-based photopolymerization. Typically, the (macro)RAFT agent and monomer were dissolved with DMSO in a Schlenk tube where the monomer to solvent (wt/vol) ratio is 1:5. The solution was subjected to three freeze-pump-thaw cycles and lastly backfilled with Ar. The Schlenk tube was then placed in the middle of a selfconstructed photoreactor and irradiated for a day. (Near) full monomer conversion (> 90%) was attained in all cases. The LED light source was a commercial strip lighting (300 LEDs, 60W total).
Synthesis of ω-RAFT end-group-functionalized linear poly(Z-L-lysine

General core cross-linked star polymer formation via RAFT-based photopolymerization.
In a similar fashion to the synthesis of linear polymers, the pre-formed macroinitiators and crosslinker N,N'-methylenebis(acrylamide) (15 mol eq. with respect to the RAFT group) were dissolved with DMSO in a Schlenk tube where the macroinitiator to solvent (wt/vol) ratio is 1:8.
The solution was subjected to three freeze-pump-thaw cycles and lastly backfilled with Ar. The
Schlenk tube was then placed in the middle of the photoreactor and irradiated for two days. Full conversion of the vinyl groups was observed. The crude sample was re-precipitated twice into DEE and dried in vacuo prior to the removal of protecting groups.
General procedure for removal of protecting groups. The carboxybenzyl groups were first removed, followed by the acetyl groups. Generally, the polymer (ca. 3 wt%) was dissolved in TFA followed by the addition of thioanisole and TFMSA (5 mol eq. each with respect to Cbz).
The solution was stirred at 0 o C for 2 h. The contents were re-precipitated thrice into DEE, washed with DEE, and dried in vacuo prior to the next step. For the removal of acetyl groups, the polymer (ca. 2 wt%) was dissolved in DMSO followed by the addition of hydrazine (11 mol eq.
with respect to the acetyl group) and the solution was stirred at 25 o C for 12 h. The polymer was re-precipitated twice into DEE, dried in vacuo, re-dissolved in water and further purified using a 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Vivaspin Centrifugal Concentrator (molecular weight cut-off 3 kDa). The purified solution was then lyophilized to yield a white fluffy product. in PBS). After another 4 h of incubation, the MTT medium was removed. DMSO (100 µL) was added and the plate was shaken at 100 rpm for 15 min. The cell viability was measured based on the absorbance of each well at 570 nm.
Haemolysis studies. The haemolytic activity was determined against human erythrocytes.
Erythrocytes were isolated from freshly drawn human blood (approval number: IRB-2015-03-040). Human blood was drawn directly into K 2 -EDTA-coated Vacutainer tubes to prevent coagulation of blood. The blood was stored at 4 o C for 1 h and centrifuged at 1000g for 10 min to get red blood cells (RBC). RBC were washed with PBS for three times (vortex mixing with PBS and centrifugation at 1000g for 10 min to remove supernatant) and RBC were re-suspended to achieve 5% (v/v) in PBS (pH 7.4). Serial dilution was done in sterilized tubes by mixing 60 µL of polymer solution (20,000 µg mL -1 ) with 60 µL of PBS. Serial dilution of the polymers in PBS was performed followed by the addition of 60 µL of erythrocyte suspension to the polymer solutions. PBS buffer (pH 7.4) was used as a negative haemolysis control and Triton X-100 (1% v/v in PBS) was used as a positive haemolysis control. The tubes containing polymer solution 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 and erythrocyte suspension were incubated for 2 h at 37 o C and 150 rpm in an inoculation shaker.
Then, RBC with polymer solutions were centrifuged at 1000g for 5 min. The supernatants (60 µL) were then transferred to each well of a fresh microtiter plate (96-well microplate) followed by the addition of 60 µL of PBS and absorbance was determined at 540 nm by using a Tecan
InfinitePro series M200 Micro plate Reader. The haemolysis percentage (H) was calculated from the following equation:
where O p is the absorbance for the polymer, O b is the absorbance for the negative control (PBS),
and O t is the absorbance for the positive control of Triton X-100. as the lowest concentration that inhibited cell growth by more than 90%.
Minimum inhibitory concentration (MIC
RESULTS AND DISCUSSION
Overall, the synthesis of the glucosamine-functionalized star polymer nanoparticle can be divided into three key stages: i) synthesis of glycopolymer macroinitiator (L-pGSA), ii)
synthesis of polylysine macroinitiator (L-pLYS), and iii) star formation followed by deprotection (Scheme 1). To synthesize the polyglucosamine-based macroinitiator L-pGSA, an 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 groups are in their protected form), was evident based on the shift in molecular weight distribution to shorter retention time (SI, Figure S4 ). Noteworthy, the inclusion of a poly(HEAm) spacer block was necessary to ensure a higher macroinitiator-to-star conversion under the current reaction conditions as we have observed poor star formation (< 20%) when no or shorter (DP n = 20) spacer block was used. HEAm was judiciously chosen for our system as poly(HEAm) are known for their excellent biocompatibility with mammalian cells and low-fouling nature. 31, 32 Meanwhile, the synthesis of the polylysine macroinitiator L-pLYS initially entails the NCA- Figure S5 and S6). GPC analysis of PZLL-yne and PZLL-RAFT however, revealed bimodal distributions (SI, Figure S7 ), which is not entirely surprising given that PZLL experiences a coil-to-helix transition at around a DP n of 15 and potentially produces a bimodal distribution as an artefact during GPC analysis. This phenomenon has recently been documented in the literature. 33 The shift in molecular weight distribution after chain extension with HEAm indicated that PZLL-RAFT was indeed still active. For the star formation step, the synthesized macroinitiators were mixed as a cocktail mixture at where S denotes for star polymer and the number indicates the average mol percentage of glycopolymer arm with respect to the total number of arms). In general, GPC analysis of Figure   2a revealed that the polymerizations were well-moderated, with star polymers having Ɖ < 1.7, except for S-pLYS (Ɖ = 3.5) because it contains star-star coupled products, while the estimated average number of arms per star particle (N arm ) was between 12 to 19 (Table 1 and SI, Figure   S13 and Table S1 ). Noteworthy, the N arm values represent estimates and not the actual molecular weights and were determined relative to polystyrene standards. Given that the star polymer usually adopts a smaller hydrodynamic volume compared to a linear counterpart of equal molecular weight, the N arm values reported in Table 1 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 pLYS contain bulky side-groups that may have created a steric congestion during star formation, thereby preventing the macroinitiators from fully inserting into the nanoparticle form.
ROP of ε-carboxybenzyl(Z)-L-lysine
Furthermore, some of the PZLL chains adopt α-helix structure and occupy larger hydrodynamic volume than random coil configuration, which adds more steric congestion to the alreadysterically-congested system. The addition of the spacer block poly(HEAm) relieved the steric hindrance (vide supra) but was insufficient to induce a higher macroinitiator-to-star conversion.
Another possible reason is that L-pGSA and L-pLYS contain some dead chains that were unable to participate in the cross-linking step and hence were 'left behind' as observed via GPC analysis. Although possible, it is unlikely that this reason alone contributed to such star conversion values as the RAFT-based photopolymerization method was previously shown to proceed with high efficiency. 27 We believe that the obtained moderate star conversion values were primarily caused by steric effects, and to a lesser extent due to the contamination of dead chains in L-pGSA and L-pLYS. It is worth mentioning that although the star polymer samples consist partially of linear polymer impurities, as shown below, the glucosamine-functionalized star polymer samples have significantly different (improved) biological properties compared to linear macromolecules. As a proof of concept, this demonstrates the advantage and difference between star and linear polymers even though the current star production pathway could potentially be further optimized to eliminate any linear polymer impurities to obtain pure star products for better comparison.
Proving that the star polymers truly comprise of mixtures of polylysine and glycopolymers is extremely challenging. However, considering that both L-pGSA and L-pLYS were composed of identical spacer lengths and types (poly(HEAm)) and used the same family of RAFT agent (trithiocarbonate), it is safe to assume that heteroarm stars were formed and not just mixtures of 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 two homoarm stars. This is especially true given that controlled radical polymerization is a statistical process. Other studies have indirectly shown the successful formation of heteroarm stars via stimuli-responsive hierarchical self-assembly 34,36 but this method of verification the formation of heteroarm stars is not possible with our system. Nevertheless, the indiscriminate incorporation of various macroinitiators to form heteroarm stars using controlled radical polymerization protocols similar to ours, as demonstrated in these reports, provides strong evidence that heteroarm glucosamine-functionalized stars were formed.
The protecting groups (carboxybenzyl and acetyl) of the star and linear polymers were removed sequentially prior to biological testing (Scheme 1, step viii). Firstly, the carboxybenzyl groups of PZLL blocks were removed in the presence of trifluoroacetic acid, trifluoromethanesulfonic acid and thioanisole, followed by the removal of acetyl protecting groups on the glycopolymer using hydrazine. Table 1 ). The size range of the star polymers was comparable to other star polymers that were made via the arm-first approach.
Although the star samples consisted of some linear polymer impurities, the DLS results indicated monomodal distributions. We postulate that the linear impurities in the star samples may be entangled with the star species when dissolved in solution, and hence were not detectable by 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 DLS. Zeta potential measurements showed that the stars are less cationic with increasing glycopolymer content (with zeta potential (ζ) values decreasing from 33.6 to 8.3 mV), which is expected given that the glucosamine moieties are not as cationic compared to polylysine.
To test the mammalian cell biocompatibility of the star polymers, human aortic smooth muscle cells (AoSMC) were used as a model cell line and the metabolic activity, an indicator of viability, was determined using the MTT assay. At 100 µg mL -1 , the cell viability was high (> 80%) for all glucosamine-functionalized star polymers (even for S-GSA 25 with the lowest degree of glucosamine functionalization) (Figure 3a) . S-LYS which does not contain any glycopolymer units was cytotoxic. At a higher sample concentration of 500 µg mL -1 , the cell viability decreased but improved with higher glucosamine content. The half maximal inhibitory concentration (IC 50 ) values for S-GSA 25 and S-GSA 50 were determined to be 337 and 369 µg mL -1 , respectively ( Figure 3b and Table 2 ). The trend observed in Figure 3 was correlated with the charge density of the star polymer nanoparticle as polymers with higher zeta potential values were more cytotoxic, most likely because of increased electrostatic interactions with the negatively charged cell surfaces.
An additional experiment was performed to ascertain the effect of the star architecture over mammalian cell biocompatibility. For this, a control sample which is a physical blend of L-LYS and L-GSA (75:25 molar ratio) that mimics the chemical composition of S-GSA 25 was subjected to similar MTT assay as above (SI, Figure S16) . Interestingly, at 100 µg mL -1 , the cell viability of S-GSA 25 was significantly higher (85%) than the control sample (41%) even 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 probability of adjacent polylysine arms from non-specific interactions with cell surfaces, giving the star polymer better human cell biocompatibility over free linear chains. It is worthwhile noting that both S-LYS and L-LYS were equally cytotoxic towards AoSMC, and the mammalian cell viability only improved with the addition of polyglucosamine-based arms.
The sample concentration at which 50% of red blood cells were lysed, defined as the HC 50 , was used as the metric for determining the haemolytic activity of the polymers. Remarkably, even at the highest polymer concentration tested (10000 µg mL -1 ), none of the star polymers were haemolytic, including S-LYS which has poor cytocompability with SMC ( Table 2 ). The good haemocompatibility for the star polymers may be attributed to the absence of hydrophobic groups, which are known to be responsible for inducing haemolytic activity. 37, 38 The antimicrobial efficacy of the synthesized nanomaterials against a range of Gram-negative and Gram-positive pathogens was determined based on their minimum inhibitory concentrations (MICs) ( Table 2 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 bacteria wall, subsequently enabling the polylysine arms to induce cell death. In contrast, the However, as shown in Figure 3 , the cytocompatibility of S-LYS with a human model cell line SMC was extremely poor (< 30% at 100 µg mL -1 ). Amongst the heteroarm stars, S-GSA 25
showed the best IC 50 /MIC (7.0). Taking into account both the HC 50 /MIC and IC 50 /MIC values, S-GSA 25 was considered to be the best performing antimicrobial agent that exhibited minimal toxicity to human cells in this study. To get an indication on the selectivity of S-GSA 25, its HC 50 /MIC value was compared to other antimicrobial agents like AMPs. S-GSA 25 outperforms all the AMPs listed in Table 2 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 MIC values than S-GSA 25, they inherently suffer from having low HC 50 (and possibly IC 50 )
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CONCLUSIONS
